An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells.

Cell Microbiol

Department of Molecular Mechanisms of Mycobacterial Infections, Institut de Pharmacologie et de Biologie Structurale, CNRS UMR5089, 205, route de Narbonne, 31077 Toulouse, France.

Published: May 2004

In the majority of individuals infected with Mycobacterium tuberculosis, the bacilli cause a long-term asymptomatic infection called latent tuberculosis, a state during which the bacilli reside within granulomas. Latently infected individuals have around 10% risk of progression to clinical disease at a later stage. Determining the state of the mycobacteria and the host cells during this latent phase, i.e. within the granulomas, would greatly improve our understanding of the physiopathology of tuberculosis, and thus enable the development of new therapeutic means to treat the one-third of the world's population who are latently infected. We have developed an in vitro model of human mycobacterial granulomas, enabling the cellular and molecular analysis of the very first steps in the host granulomatous response to either mycobacterial compounds or live mycobacterial species. In vitro mycobacterial granulomas mimic natural granulomas very well, with the progressive recruitment of macrophages around live bacilli or mycobacterial antigen-coated beads, their differentiation into multinucleated giant cells and epithelioid cells, and the final recruitment of a ring of activated lymphocytes. Besides morphological similarities, in vitro granulomas also functionally resemble natural ones, with the development of intense cellular co-operation and intracellular mycobactericidal activities.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1462-5822.2004.00371.xDOI Listing

Publication Analysis

Top Keywords

mycobacterial granulomas
12
host cells
8
latently infected
8
granulomas
7
mycobacterial
6
vitro
4
vitro dual
4
dual model
4
model mycobacterial
4
granulomas investigate
4

Similar Publications

An mRNA vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy.

Mol Ther Nucleic Acids

March 2025

Department of Microbiology, School of Life Sciences, Fudan University, Shanghai 200438, China.

Article Synopsis
  • A new mRNA vaccine for tuberculosis (TB) shows strong effectiveness in a zebrafish model, offering both prevention and treatment benefits.
  • Zebrafish that received the mRNA vaccine lived longer after being exposed to TB and showed significantly reduced bacterial levels when treated after infection.
  • The vaccine not only activates important DNA repair systems for immune function but also promotes cell survival and bacterial killing without triggering harmful cell death responses.
View Article and Find Full Text PDF

Mycobacteria infections are caused by species of the Mycobacterium tuberculosis complex (MTB) and other species called Non-Tuberculosis Mycobacteria (NTM). Identification of mycobacteria species is very important to define treatment and it can be achieved by direct culture. However, the lack of clear protocols regarding the use of culture or molecular tests on specimens diagnosed with granulomatous lesions causes delays in the diagnosis of the etiological agents and, consequently, the definition of the right treatment.

View Article and Find Full Text PDF

In cats, mycobacteriosis tends to present in a syndromic manner, with cases either being due to tuberculosis (TB) (in countries where TB is endemic), one of the "leprosy-like" diseases affecting the skin and subcutis, panniculitis caused by infection of subcutaneous tissues generally with rapidly growing Mycobacteria spp. or widely disseminated granulomatous disease, which is usually caused by members of the Mycobacterium avium-intracellulare complex (MAC). Disseminated MAC disease is rare, but when it occurs, usually develops in immunocompromised hosts with defective cell-mediated immunity.

View Article and Find Full Text PDF

FadD32, a fatty acyl-AMP ligase, plays an indispensable role in mycobacterial mycolic acid synthesis and is a validated target for tuberculosis (TB) drug development. The crystal structure of (Mtb)FadD32 has laid the foundation of structure-based drug discovery against this crucial enzyme. Here, we screened the "isoxazole" scaffold containing molecules against MtbFadD32 and identified a compound 2,4-dibromo-6-[3-(trifluoromethyl)-1,2-oxazol-5-yl]phenol (M1) with specific inhibitory activity against Mtb.

View Article and Find Full Text PDF

Cutaneous Atypical Mycobacterial Infections: A Brief Review.

Indian Dermatol Online J

October 2024

Department of Dermatology and Venereology, AIIMS, New Delhi, India.

Nontuberculous mycobacterial (NTM) infections are increasingly recognized, particularly in tropical regions and are often found in immunocompetent individuals. These infections are emerging as significant health concerns, especially pulmonary NTM, which is reported more frequently and is known to be associated with hospital environments. While pulmonary NTM infections are on the rise, partly due to drug resistance and possible patient-to-patient transmission, there is no current evidence indicating an increase in cutaneous NTM infections.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!